Use of CRF antagonists and renin-angiotensin system inhibitors
作者： Anthony A. Fossa
DOI:
关键词: Antagonist 、 Biology 、 Renin–angiotensin system 、 Internal medicine 、 Pharmacology 、 Companion animal 、 Endocrinology 、 Therapeutic effect 、 Heart failure
摘要: The present invention relates to compositions and methods of achieving a therapeutic effect including, but not limited to, the treatment congestive heart failure or hypertension in an animal, preferably mammal including human subject companion using corticotropin releasing factor (CRF) antagonist renin-angiotensin system (RAS) inhibitor.
lens.org 参考文章(7)
William Stephen Faraci, Willard McKowan Welch, Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity ,(1999)
Yuhpyng L. Chen, Pyrazolo and pyrrolopyridines ,(1995)
Yuhpyng Liang Chen, Pyrazolopyrimidines as crf antagonists ,(1993)
Yuhpyng Liang Pfizer Global Res. and Dev. Chen, Corticotropin releasing factor antagonists ,(1995)
Gene M. Bright, Willard M. Welch, Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity ,(1995)
Gene Michael Bright, Amino-substituted pyrazoles having crf antagonistic activity ,(1993)
Anthony Andrea Fossa, Yuhpyng Liang Chen, New uses for corticotropin releasing factor (CRF) antagonists ,(1996)